African vaccine maker plans to improve production capacity sevenfold by 2013 Biovac Institute, a South African vaccine maker, said Monday that it is dealing with other major pharmaceutical firms to improve its annual capacity sevenfold to 35 million dosages by 2013, Reuters reviews. Morena Makhoana, the company’s deputy chief executive, said that 25 million of those doses will remain in Africa. We are in discussions with Sanofi-Pasteur, a unit of Sanofi-Aventis, with GlaxoSmithKline and with Wyeth, who are called Pfizer now, and all three of them have shown a willingness to enter a technology transfer with one, or a few, of their vaccines currently in the South African marketplace, Makhoana said.Some of the current scar treatments being offered by dermatologists contains collagen injection, autologous unwanted fat transfer, dermabrasion, microdermabrasion, laser treatment, skin surgery and epidermis grafting. The process of collagen injection consists of injecting collagen which is definitely stated in the body into the scars in reducing their appearance. The fat transfer process involves taking unwanted fat from other areas of the body and injecting it into your marks to fill them out and make the look of them less visible. Dermabrasion involves eliminating a thin layer of the surface of the skin. It does not function well for all kinds of marks. Microdermabrasion uses aluminium oxide crystals to greatly help remove surface pores and skin. Laser treatment consists of using lasers of varying wavelengths to help reduce the inflammation around the scars.